Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|6|1|35-44

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.6, Iss.1, 2006-02, pp. : 35-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans

By  

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 665-682

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of adeno-associated viral vectors

By Lin Shih-Wen   Ertl Hildegund CJ  

Future Virology, Vol. 3, Iss. 5, 2008-09 ,pp. : 491-503

Future Medicine

Access to resources Recommend Favorite

Production of Non Viral DNA Vectors

By  

Current Gene Therapy, Vol. 10, Iss. 6, 2010-12 ,pp. : 487-507

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccinia Viral / Retroviral Chimeric Vectors

By  

Current Gene Therapy, Vol. 4, Iss. 4, 2004-12 ,pp. : 417-426

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance

By  

Current Medicinal Chemistry, Vol. 24, Iss. 26, 2017-09 ,pp. : 2860-2886

Bentham Science Publishers

Access to resources Recommend Favorite